R-Tech Ueno: Announcement On Collaborative Development Of Therapeutic Agent For Diabetic Retinopathy And Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) With Hokkaido University
TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573)
R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with a group led by Professor Susumu Ishida and Associate Professor Kousuke Noda of the Department of Ophthalmology, Graduate School of Medicine from Hokkaido University. The research is in the application of a new VAP-1 inhibitor (Development Code: RTU-1096), which is under our development for treatment of diabetic retinopathy (DR) and diabetic macular edema.
Help employers find you! Check out all the jobs and post your resume.
R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with a group led by Professor Susumu Ishida and Associate Professor Kousuke Noda of the Department of Ophthalmology, Graduate School of Medicine from Hokkaido University. The research is in the application of a new VAP-1 inhibitor (Development Code: RTU-1096), which is under our development for treatment of diabetic retinopathy (DR) and diabetic macular edema.
Help employers find you! Check out all the jobs and post your resume.